These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 56853)

  • 1. Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
    Agrup G; Bengtsson M; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1976; 56(1):27-31. PubMed ID: 56853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
    Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    Césarini JP; Meunier M
    Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
    [No Abstract]   [Full Text] [Related]  

  • 7. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of determining spermidine in the urine of patients with melanoblastoma of the skin].
    Smirnova EV; Khachaturian LM
    Vopr Onkol; 1976; 22(11):78-81. PubMed ID: 1014507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical diagnosis of melanoma].
    Agrup G
    Lakartidningen; 1976 Feb; 73(7):526-8. PubMed ID: 1250044
    [No Abstract]   [Full Text] [Related]  

  • 11. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.
    Pavel S; Muskiet FA; Budesínská A; Duchon J
    Tumori; 1981 Aug; 67(4):325-32. PubMed ID: 6797117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
    Ichihasi M; Mojamdar M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Melanoma metabolites (proceedings)].
    Rorsman H
    Lakartidningen; 1978 Dec; 75(49):4596-7. PubMed ID: 723347
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of occult metastatic melanoma by urine chromatography.
    Blois MS; Banda PW
    Cancer Res; 1976 Sep; 36(9 pt.1):3317-23. PubMed ID: 975093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased excretion of indolemelanogens in malignant melanoma without liver metastasis].
    Schwartze G; Haneke E
    Dermatol Monatsschr; 1969; 155(2):99-102. PubMed ID: 5386292
    [No Abstract]   [Full Text] [Related]  

  • 17. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichochromuria in melanosis of melanoma.
    Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
    Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Excretion of 3-4-dihydroxyphenyloalanin (DOPA) in the urine of patients with malignant melanoma of the organ of vision].
    Kruszczyński T
    Klin Oczna; 1972; 42(2):687-91. PubMed ID: 5022207
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichochromes in the urine of melanoma patients.
    Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
    J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.